Redwood Scientific Technologies Inc

Redwood Scientific Technologies Inc. Stock Analysis RSCI

United States Consumer Staples Nano Cap
Redwood Scientific Technologies, Inc. develops and markets homeopathic products which feature oral strip delivery technology. The company is headquartered in Albany, New York. The company went IPO on 2008-03-12. RST utilizes Patent-pending, sublingual strip delivery technology that enhances bioavailability. The main product, Prolongz, is designed to treat premature ejaculation in men. Prolongz has been registered with the FDA #079526408, allowing Redwood to elevate ourselves from competitors. Redwoods Prolongz is on course to establish ourselves as the industry leader for the adult male sexual performance dysfunction market through our membership (subscription) model. The firm is aggressively expanding our customer population through heavy investments in national cable television commercials and infomercials which also drives consumer awareness and retail sales. Source: Crunchbase
Read More

Redwood Scientific Technologies Inc (RSCI) Chart

Key Statistics of Redwood Scientific Technologies Inc (RSCI)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.01$0.01

Today's Open

$0.01

Volume

192.00

P/E Ratio (TTM)

-

52 Week Range

$0.00$0.10

Market Cap

2.27M

Avg. Volume

104.50

Dividend Yield

-

Financial Metrics & Statements of Redwood Scientific Technologies Inc (RSCI)

FAQ's for Redwood Scientific Technologies Inc (RSCI)

  • According to Musaffa’s Shariah screening methodology, Redwood Scientific Technologies Inc (RSCI) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.